Fumio Nishikaku
Director/Board Member at HuLA immune, Inc.
Fumio Nishikaku active positions
| Companies | Position | Start | End |
|---|---|---|---|
HuLA immune, Inc.
 HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Director/Board Member | - | - |
MATRIXOME, Inc.
 MATRIXOME, Inc. Miscellaneous Commercial ServicesCommercial Services MATRIXOME, Inc. is a Japanese regenerative medicine company founded in 2015. The company is based in Osaka, Japan and develops regenerative medicine using laminin E8 fragment technology. | Director/Board Member | - | - |
Career history of Fumio Nishikaku
Statistics
International
| Japan | 3 |
Operational
| Director/Board Member | 2 |
Sectoral
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
HuLA immune, Inc.
HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Health Technology |
MATRIXOME, Inc.
MATRIXOME, Inc. Miscellaneous Commercial ServicesCommercial Services MATRIXOME, Inc. is a Japanese regenerative medicine company founded in 2015. The company is based in Osaka, Japan and develops regenerative medicine using laminin E8 fragment technology. | Commercial Services |
- Stock Market
- Insiders
- Fumio Nishikaku
- Experience
